| Regulation of nanomedicines in the EU: distilling lessons from the pediatric and the advanced therapy medicinal products approaches. | |
| | |
MedLine Citation:
|
PMID: 20025470 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
As the market for nanomedicines in the EU is growing, the development of regulatory guidance in this area assumes priority. Currently, the nanomedicine market is poised at a critical stage wherein clear regulatory guidance is imperative in providing for clarity and legal certainty to manufacturers of nanomedicine. The regulation of the pharmaceutical sector in the EU has witnessed several developments and innovations guided by the philosophy of single market and balancing the principle of ensuring high public health protection and safety of medicines. Both the pediatric and the advanced therapies medicinal products (ATMP) regimes offer important regulatory guidance that could be adopted for the regulation of nanomedicines in the EU. |
| | |
Authors:
|
Nupur Chowdhury |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Nanomedicine (London, England) Volume: 5 ISSN: 1748-6963 ISO Abbreviation: Nanomedicine (Lond) Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2009-12-22 Completed Date: 2010-03-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278111 Medline TA: Nanomedicine (Lond) Country: England |
Other Details:
|
Languages: eng Pagination: 135-42 Citation Subset: IM |
Affiliation:
|
Department of Legal & Economic Governance Studies, School of Management & Governance, University of Twente, Institutenweg, NL-7500 AE Enschede, The Netherlands. n.chowdhury@utwente.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
European Union Humans Nanomedicine / legislation & jurisprudence* Social Control, Formal |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-...
Next Document: Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care.